- Home
- LFVN vs OKYO Comparison
LFVN vs OKYO Comparison
Compare LFVN & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFVN | OKYO |
|---|---|---|
| Founded | N/A | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.0M | 81.3M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LFVN | OKYO |
|---|---|---|
| Price | $6.69 | $1.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $11.00 | $6.33 |
| AVG Volume (30 Days) | ★ 851.7K | 60.1K |
| Earning Date | 05-06-2026 | 07-18-2025 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | ★ 226.09 | N/A |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $203,204,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $22.17 | ★ N/A |
| Revenue Growth | ★ 1.86 | N/A |
| 52 Week Low | $3.90 | $1.42 |
| 52 Week High | $15.00 | $3.35 |
Technical Indicators
Market Signals| Indicator | LFVN | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 46.50 | 47.86 |
| Support Level | $5.67 | $1.47 |
| Resistance Level | $11.71 | $1.73 |
| Average True Range (ATR) | 1.22 | 0.09 |
| MACD | -0.31 | 0.00 |
| Stochastic Oscillator | 19.16 | 65.22 |
Price Performance
Historical ComparisonAbout LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.